Neurocrine Biosciences Inc. (NBIX) tumbled -5.1% or -4.48 to $83.44. It is close to 463046 shares traded, which is 58.52% compare to the average total volume 791238. The market cap of NBIX is $7.45 billion. The year to date change is 10.87%. The 52 week price range is from $39.21 to $92.98. Price of NBIX have changed -2.95% during last week. It have changed 3.95% over last month, 27.64% over last 3 months, 56.08% over last 6 months and 100.32% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 84.77. It is 1.59% above current price. The 200-day Moving Averages for NBIX is 64.94. It is -22.17% below current price. The 52-week High is 92.98. It is 11.43% from the current price. The 52-week Low is 39.21. It is -53.01% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBIX is 7.68 on 2018-02-28. Short % to float is 7.14%. There are some statistics of NBIX. It is has market cap $7.45 billion. The share outstanding is 89.27 million. The average volume is 791238. The revenue is 161.63M. The gross profit is 160.37M. The percent of top 15 Institution holding is 85.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is -38.98%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is -23.10%.